X-120427852-GAAC-G
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_002294.3(LAMP2):c.*3468_*3470delGTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0108 in 111,164 control chromosomes in the GnomAD database, including 33 homozygotes. There are 415 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 33 hom., 415 hem., cov: 22)
Failed GnomAD Quality Control
Consequence
LAMP2
NM_002294.3 3_prime_UTR
NM_002294.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.17
Publications
0 publications found
Genes affected
LAMP2 (HGNC:6501): (lysosomal associated membrane protein 2) The protein encoded by this gene is a member of a family of membrane glycoproteins. This glycoprotein provides selectins with carbohydrate ligands. It may play a role in tumor cell metastasis. It may also function in the protection, maintenance, and adhesion of the lysosome. Alternative splicing of this gene results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2008]
LAMP2 Gene-Disease associations (from GenCC):
- Danon diseaseInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant X-120427852-GAAC-G is Benign according to our data. Variant chrX-120427852-GAAC-G is described in ClinVar as [Likely_benign]. Clinvar id is 367748.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMP2 | ENST00000200639.9 | c.*3468_*3470delGTT | 3_prime_UTR_variant | Exon 9 of 9 | 1 | NM_002294.3 | ENSP00000200639.4 | |||
LAMP2 | ENST00000434600.6 | c.*629_*631delGTT | 3_prime_UTR_variant | Exon 9 of 9 | 1 | ENSP00000408411.2 |
Frequencies
GnomAD3 genomes AF: 0.0108 AC: 1203AN: 111112Hom.: 33 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
1203
AN:
111112
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0108 AC: 1203AN: 111164Hom.: 33 Cov.: 22 AF XY: 0.0124 AC XY: 415AN XY: 33488 show subpopulations
GnomAD4 genome
AF:
AC:
1203
AN:
111164
Hom.:
Cov.:
22
AF XY:
AC XY:
415
AN XY:
33488
show subpopulations
African (AFR)
AF:
AC:
56
AN:
30660
American (AMR)
AF:
AC:
470
AN:
10458
Ashkenazi Jewish (ASJ)
AF:
AC:
14
AN:
2638
East Asian (EAS)
AF:
AC:
405
AN:
3534
South Asian (SAS)
AF:
AC:
19
AN:
2706
European-Finnish (FIN)
AF:
AC:
163
AN:
5851
Middle Eastern (MID)
AF:
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
AC:
47
AN:
52908
Other (OTH)
AF:
AC:
29
AN:
1513
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
36
73
109
146
182
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
122
AN:
2519
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Danon disease Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
May 20, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hypertrophic cardiomyopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.